PMID- 32923557
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220416
IS  - 2352-3441 (Print)
IS  - 2352-3441 (Electronic)
IS  - 2352-3441 (Linking)
VI  - 6
IP  - 4
DP  - 2020 Dec
TI  - Primary Total Hip Arthroplasty in Hispanic/Latino Patients: An Updated Nationwide 
      Analysis of Length of Stay, 30-Day Outcomes, and Risk Factors.
PG  - 721-725
LID - 10.1016/j.artd.2020.07.035 [doi]
AB  - BACKGROUND: This study explored recent time trends in length of stay (LOS), 
      30-day outcomes, and risk factors for adverse events (AEs) pertaining to total 
      hip arthroplasty in the Hispanic and Latino population. METHODS: A total of 4107 
      Hispanic and Latino patients who underwent primary total hip arthroplasty between 
      2011 and 2017 were identified using the American College of Surgeons National 
      Surgical Quality Improvement Program database. Annual trends in LOS and 30-day 
      outcomes (readmission, reoperation, complications, and mortality) were calculated 
      using univariate mixed-effect regression analyses. Risk factors for AEs were 
      determined using multivariate analyses. RESULTS: Between 2011 and 2017, there was 
      a significant reduction in LOS >2 midnights (67.6% to 29.5%, P < .001) among 
      Hispanic patients, which was similar to that among non-Hispanic white patients 
      and was also accompanied with improvements in comorbidity profiles and shorter 
      operative times. Postoperatively, the annual rates of 30-day outcomes were 
      comparable with those of white patients (P > .05). Chronic kidney disease, the 
      American Society of Anesthesiologists score >2, and chronic steroid use were the 
      strongest independent predictors for AEs. CONCLUSIONS: In the context of 
      historically lower arthroplasty outcomes among the Hispanic and Latino 
      population, current evidence suggests a receding tide, with annual trends showing 
      significantly shorter LOS and comparable overall 30-day outcomes with whites. 
      Patients with chronic kidney disease, the American Society of Anesthesiologists 
      score >2, and chronic steroid use are at the highest risk for developing 30-day 
      AEs.
CI  - (c) 2020 The Authors.
FAU - Gronbeck, Christian
AU  - Gronbeck C
AD  - University of Connecticut School of Medicine, Farmington, CT, USA.
FAU - Cusano, Antonio
AU  - Cusano A
AD  - Department of Orthopaedic Surgery, University of Connecticut Health Center, 
      Farmington, CT, USA.
FAU - Cardenas, Justin M
AU  - Cardenas JM
AD  - Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, TX, USA.
FAU - Harrington, Melvyn A
AU  - Harrington MA
AD  - Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, TX, USA.
FAU - Halawi, Mohamad J
AU  - Halawi MJ
AD  - Department of Orthopaedic Surgery, Baylor College of Medicine, Houston, TX, USA.
LA  - eng
PT  - Journal Article
DEP - 20200827
PL  - United States
TA  - Arthroplast Today
JT  - Arthroplasty today
JID - 101681808
PMC - PMC7475048
OTO - NOTNLM
OT  - Hip arthroplasty
OT  - Hispanic and Latino
OT  - Outcomes
OT  - Risk factors
EDAT- 2020/09/15 06:00
MHDA- 2020/09/15 06:01
PMCR- 2020/08/27
CRDT- 2020/09/14 05:55
PHST- 2020/05/29 00:00 [received]
PHST- 2020/07/16 00:00 [revised]
PHST- 2020/07/22 00:00 [accepted]
PHST- 2020/09/14 05:55 [entrez]
PHST- 2020/09/15 06:00 [pubmed]
PHST- 2020/09/15 06:01 [medline]
PHST- 2020/08/27 00:00 [pmc-release]
AID - S2352-3441(20)30154-0 [pii]
AID - 10.1016/j.artd.2020.07.035 [doi]
PST - epublish
SO  - Arthroplast Today. 2020 Aug 27;6(4):721-725. doi: 10.1016/j.artd.2020.07.035. 
      eCollection 2020 Dec.